POCI Precision Optics Corporation

NEUTRAL Impact: 4/10 PRESS-RELEASE
Horizon days Filed Mar 26, 2026 Processed 2mo ago Wire GlobeNewswire
Press release: offering
Latest settled — T+20d ⚠ clustered
POCI ▲ 0.00% at T+20d
NEUTRAL call ✗ call lost 0.00% · α vs SPY -12.74% · entry $4.19 → $4.19
Next anchor: T+60d in 13d
Currently $5.68 · +35.56% from $4.19 entry
Entry anchored
Mar 26, 12:46 PM ET
via Databento tick
T+1d
+0.24%
call +0.24% · α +0.60%
$4.20
settled 3mo ago
T+5d
-4.53%
call -4.53% · α -8.40%
$4.00
settled 2mo ago
T+20d
0.00%
call 0.00% · α -12.74%
$4.19
settled 7w ago
T+60d
call — · α —
in 13d

Price Chart

Loading chart...

Executive Summary

Precision Optics Corporation (POCI) announced it is commencing an underwritten public offering of its common stock, subject to market conditions and regulatory filings. The offering will be made via a shelf registration statement, with Lucid Capital Markets as sole book-runner, though specific terms such as size, pricing, and use of proceeds were not disclosed.

Actionable Insight

Traders should monitor for the filing of the preliminary prospectus supplement to assess offering size, pricing, and use of proceeds, which will clarify the dilutive impact and strategic intent.

Key Facts

  • Precision Optics Corporation (POCI) is initiating an underwritten public offering of common stock or common stock equivalents.
  • The offering is subject to market conditions; no assurance it will be completed.
  • Lucid Capital Markets is acting as sole book-running manager.
  • Offering is made under a shelf registration (Form S-3) filed June 2024 and declared effective June 14, 2024.
  • Preliminary prospectus supplement will be filed with the SEC; no financial terms disclosed in this release.

Financial Impact

Potential dilution and capital raise dependent on final offering size and pricing, which are not disclosed.

dilutionequitycash

Risk Factors

  • Potential share dilution upon completion of the offering.
  • Market reaction may be negative if offering is priced at a significant discount to current market value.
  • Uncertainty around timing and final terms increases volatility risk ahead of definitive disclosure.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3263387
5 reports for POCI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for POCI — sortable, filterable
Type Now
May 13, 2026
27d ago
Press Release
BULLISH ★ 7/10
$4.78 $4.94▲ +3.35%▲ +4.07%$5.68 (+18.83%)
Mar 30, 2026
10w ago
Insider Cluster
BULLISH ★ 7/10
$4.20 $3.90▼ −7.14%▼ −11.44%$5.68 (+35.24%)
Mar 27, 2026
10w ago
Press Release
NEUTRAL ★ 5/10
$4.19 $4.00▼ −4.53%▼ −8.40%$5.68 (+35.56%)
Mar 26, 2026
10w ago
424B5
NEUTRAL ★ 4/10
$4.19 $4.00▼ −4.53%▼ −8.40%$5.68 (+35.56%)
Mar 26, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$4.19 $4.00▼ −4.53%▼ −8.40%$5.68 (+35.56%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (10h 56m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access